Resistance to Change
- PMID: 35799023
- PMCID: PMC9263069
- DOI: 10.1007/s43032-022-01015-9
Resistance to Change
Abstract
Advances in medical technology do not follow a smooth process and are highly variable. Implementation can occasionally be rapid, but often faces varying degrees of resistance resulting at the very least in delayed implementation. Using qualitative comparative analysis, we have evaluated numerous technological advances from the perspective of how they were introduced, implemented, and opposed. Resistance varies from benign - often happening because of inertia or lack of resources to more active forms, including outright opposition using both appropriate and inappropriate methods to resist/delay changes in care. Today, even public health has become politicized, having nothing to do with the underlying science, but having catastrophic results. Two other corroding influences are marketing pressure from the private sector and vested interests in favor of one outcome or another. This also applies to governmental agencies. There are a number of ways in which papers have been buried including putting the thumb on the scale where reviewers can sabotage new ideas. Unless we learn to harness new technologies earlier in their life course and understand how to maneuver around the pillars of obstruction to their implementation, we will not be able to provide medical care at the forefront of technological capabilities.
Keywords: Conflicts of interest; Editorial process; Peer review; Resistance to change; Technology advancement.
© 2022. Society for Reproductive Investigation.
Conflict of interest statement
Dr. Evans and Britt have publications on some of the topics detailed. Dr. Evans has patents on the Fetal Reserve Index (which is not mentioned in the manuscript), but the topic of electronic fetal monitoring is.
Figures
References
-
- McGeary Michael, Hanna Kathi E., eds. (2004). Sources of funding for biomedical research. Strategies to Leverage Research Funding. pp. 37–54. ISBN 978–0–309–09277–7.
-
- Mervis, Jeffrey (2017). Data check: U.S. Government share of basic research funding falls below 50%. Science. 10.1126/science.aal0890.
-
- Slaughter S, Rhoades G. The emergence of a competitiveness research and development policy coalition and the commercialization of academic science and technology. Sci Technol Human Values. 2016;21(3):303–339. doi: 10.1177/016224399602100303.JSTOR689710. - DOI
-
- Cohen A, Hanft R. Policy directions for effctive evaluation and management. In: Hanft ABCaRS, editor. Technology in American health care. Ann Arbor, MI: University of Michigan Press; 1994. p. 480.
Publication types
LinkOut - more resources
Full Text Sources